Status:
COMPLETED
A Study of a Home-based Exercise Intervention for Patients With Acute Myeloid Leukaemia (AML)
Lead Sponsor:
Toronto Rehabilitation Institute
Collaborating Sponsors:
University Health Network, Toronto
The Leukemia and Lymphoma Society
Conditions:
Acute Myeloid Leukemia
Exercise
Eligibility:
All Genders
40-79 years
Phase:
PHASE2
Brief Summary
Fatigue is the most common and disabling symptom in acute myeloid leukaemia (AML). Studies in other cancer patients with fatigue have shown that exercise improves both fatigue and quality of life (QOL...
Detailed Description
Background: Fatigue is the most common and disabling symptom affecting patients with acute myeloid leukaemia (AML). Fatigue is negatively associated with quality of life (QOL) and daily function, and ...
Eligibility Criteria
Inclusion
- Completion of induction and consolidation chemotherapy
- AML with histologically confirmed complete remission
- Fluency in English (or availability of bilingual caregiver and fluency in language for which validated translations of the FACT-Fatigue exist)
- Potential participants must also be screened with the Physical Activity Readiness Questionnaire (PAR-Q \& PAR-MedX) and receive physician approval to participate in an exercise program
Exclusion
- Another active malignancy
- Life expectancy \< 3 months
- Severe or unstable cardiorespiratory disease
- Bone marrow transplant candidates
Key Trial Info
Start Date :
October 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00764231
Start Date
October 1 2008
End Date
April 1 2011
Last Update
February 8 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Princess Margaret Hospital
Toronto, Ontario, Canada, M5G 1Z5